Ravi Bhangadia's most recent trade in Novelix Pharmaceuticals Ltd. was a Disposal of 66,333 Equity Shares done at an average price of Rs. 10 . Disclosure was reported to the exchange on Sept. 17, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Ravi Bhangadia's has made SAST transactions in Novelix Pharmaceuticals Ltd. recently where a Disposal of 50,707,336 shares done . Disclosure was reported to the exchange on Sept. 16, 2024.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trimurthi | Ravikumar Bhangadia & PACs | Promoter | Disposal | 16 Oct 2024 | 50,707,336 | 350,000 (3.52%) | 50.96% | - | 16 Sep 2024 16 Sep 2024 |
SAST (29(2)) | - | Off Market | |
| Trimurthi | Ravikumar Bhangadia | Promoter | Disposal | 17 Sep 2024 | 66,333 | 0 (0%) | 0.67% | 10 | 663,330 | 16 Sep 2024 16 Sep 2024 |
Insider Trading | Equity Shares | Off Market |
| Trimurthi | Ravi Bhangadia | Promoter Group | Acquisition | 22 Mar 2021 | 24,833 | 66,333 (0.82%) | 0.31% | 4.9 | 122,676 | 19 Mar 2021 19 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Trimurthi | Ravi Bhangadia | Promoter Group | Acquisition | 22 Mar 2021 | 24,833 | 66,333 (0.82%) | 0.31% | 0 | 0 | 19 Mar 2021 19 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Trimurthi | Ravi Bhangadia | Promoter | Acquisition | 19 Mar 2021 | 36,500 | 41,500 (0.51%) | 0.45% | - | 17 Mar 2021 18 Mar 2021 |
SAST (29(2)) | - | Market | |
| Trimurthi | Ravi Bhangadia | Promoter Group | Acquisition | 18 Mar 2021 | 36,500 | 41,500 (0.51%) | 0.45% | 0 | 0 | 17 Mar 2021 18 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Trimurthi | Ravi Bhangadia | Promoter Group | Acquisition | 03 Mar 2021 | 5,000 | 5,000 (0.06%) | 0.06% | 0 | 0 | 02 Mar 2021 02 Mar 2021 |
Insider Trading | Equity Shares | Gift |